Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Polymorphism and Israeli Top-level Athletes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01319071
Recruitment Status : Unknown
Verified March 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : March 21, 2011
Last Update Posted : March 21, 2011
Sponsor:
Collaborator:
Wingate Institute
Information provided by:
Hillel Yaffe Medical Center

Tracking Information
First Submitted Date March 17, 2011
First Posted Date March 21, 2011
Last Update Posted Date March 21, 2011
Study Start Date April 2011
Estimated Primary Completion Date December 2011   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: March 17, 2011)
Identification of genes related to top-level athletes [ Time Frame: Four months ]
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Genetic Polymorphism and Israeli Top-level Athletes
Official Title Not Provided
Brief Summary It is still unknown whether different genetic elements play a role in athletes' ability to create their area of specificity.In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls. Few of these genes were found to be associated with athletic performance and area of specificity. Since then a few more genes have been found that are related to athletic performance, and our aim in the current study is to expand our research to these new genes which include 3 genetic cascades: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
Whole blood
Sampling Method Probability Sample
Study Population Athletes training at the Wingate Institute
Condition Top-level Athletes
Intervention Other: Blood sample
Extraction of blood sample from top-level athletes
Study Groups/Cohorts
  • Top-level athletes
    Intervention: Other: Blood sample
  • Control group
    Intervention: Other: Blood sample
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: March 17, 2011)
200
Original Estimated Enrollment Same as current
Estimated Study Completion Date December 2012
Estimated Primary Completion Date December 2011   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Top-level athletes
  • Other athletes

Exclusion Criteria:

  • All others
Sex/Gender
Sexes Eligible for Study: All
Ages 14 Years to 40 Years   (Child, Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT01319071
Other Study ID Numbers 0015-11-HYMC
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Eias Kassem, MD, Hillel Yaffe Medical Center
Study Sponsor Hillel Yaffe Medical Center
Collaborators Wingate Institute
Investigators Not Provided
PRS Account Hillel Yaffe Medical Center
Verification Date March 2011